136 related articles for article (PubMed ID: 9145070)
1. Axillary lymph node dissection: is it required in T1a breast cancer?
Chontos AJ; Maher DP; Ratzer ER; Fenoglio ME
J Am Coll Surg; 1997 May; 184(5):493-8. PubMed ID: 9145070
[TBL] [Abstract][Full Text] [Related]
2. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma.
Markopoulos C; Kouskos E; Gogas H; Mandas D; Kakisis J; Gogas J
Am Surg; 2000 Nov; 66(11):1011-3. PubMed ID: 11090007
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW
J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node metastases associated with small invasive breast carcinomas.
Maibenco DC; Weiss LK; Pawlish KS; Severson RK
Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
7. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
8. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
[TBL] [Abstract][Full Text] [Related]
9. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
Hieken TJ; Velasco JM
Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
[TBL] [Abstract][Full Text] [Related]
10. T1a and T1b breast cancer: a twelve-year experience.
Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
[TBL] [Abstract][Full Text] [Related]
11. Predictors of axillary lymph node metastasis in T1 breast carcinoma.
Shoup M; Malinzak L; Weisenberger J; Aranha GV
Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085
[TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node metastasis in stage T1a breast cancer: a pathologic review of 82 patients.
Whitten TM; Fraser HR; Christensen WN; Turk PS
Am Surg; 1997 Feb; 63(2):144-9. PubMed ID: 9012428
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node status of T1 primary breast cancer in a diverse population.
Madan AK; Macareo L; Winfrey K; Beech DJ
Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
[TBL] [Abstract][Full Text] [Related]
15. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
16. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node dissection in breast cancer: an evolving question?
Lagares-Garcia JA; Garguilo G; Kurek S; LeBlond G; Diaz F
Am Surg; 2000 Jan; 66(1):66-72. PubMed ID: 10651351
[TBL] [Abstract][Full Text] [Related]
18. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
[TBL] [Abstract][Full Text] [Related]
19. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
20. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
